High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$13.8M
$13,807,997
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
RPRX
S
Royalty Pharma plc
Lloyd George W.
• Officer • EVP, Investments & CLO
10b5-1 Sell
2025-12-18
$1,180,053Large
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Investments & CLO
10b5-1 Sell
|
2025-12-18 | $1,180,053Large | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Lloyd George W.
• Officer • EVP, Investments & CLO
10b5-1 SellΔOwn -72.1%
2025-12-17
$3,060,280Large
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Investments & CLO
10b5-1 SellΔOwn -72.1%
|
2025-12-17 | $3,060,280Large | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Lloyd George W.
• Officer • EVP, Investments & CLO
10b5-1 SellΔOwn -50.0%
2025-12-03
$4,375,008Large
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Investments & CLO
10b5-1 SellΔOwn -50.0%
|
2025-12-03 | $4,375,008Large | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Lloyd George W.
• Officer • EVP, Investments & CLO
10b5-1 SellΔOwn -43.2%
2025-11-19
$5,192,656Whalex8
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Investments & CLO
10b5-1 SellΔOwn -43.2%
|
2025-11-19 | $5,192,656Whalex8 | S | Form 4 |